MyFinsight
Home
About
Contact
ltrn: the income statement
Download
Download image
Net loss
-$4,177,423
Other income, net
$71,456
Interest income
$100,921
Loss from operations
-$4,349,800
Total operating
expenses
$4,349,800
Research and development
$2,436,971
General and
administrative
$1,912,829
Back
Back
Income Statement
source: myfinsight.com
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)